…if this turns out to indeed be the case, is there anyway to gauge how much further in the ANDA process MNTA has to go to attain approval?
Not with any precision. However, based on the rumored bioequivalence trial, I may update the probabilities in #msg-59000596 to make them somewhat more bullish.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”